Argitalpenak
- Type-1 Cannabinoid receptor activity during Alzheimer's disease progression Journal of Alzheimer's Disease (JAD), 2014; 42, 761 - 766
- Galanin activated Gi/o-proteins in human and rat central nervous systems Neuropeptides, 2014; 48, 295 - 304
- Anatomical distribution of lipids in human brain cortex by imaging mass spectrometry Journal of the American Society for Mass Spectrometry, 2011; 22, 329 - 338
- Nutritional Omega-3 deficiency abolishes endocannabinoid mediated neuronal functions Nature Neuroscience, 2011; 14(3), 345 - 50
- Matrix Assisted Laser Desorption Ionization Imaging Mass Spectrometry In Lipidomics Analytical & Bioanalytical Chemistry, 2011; 401, 29 - 51
- Distribution of lipids in human brain Analytical & Bioanalytical Chemistry, 2011; 401, 89 - 101
- Cannabinoid applications in glaucoma [Aplicaciones de los cannabinoides en glaucoma] Archivos de la Sociedad Española de Oftalmología, 2011; 86, 16 - 23
- Effect of synthetic cannabinoid CB1 agonist (WIN 55212-2) and antagonist (AM251) on intraocular pressure in rat Glaucoma: Etiology, Pathogenesis and Treatments (Ed.: Z.G. Fei and Seiji Zeng), 2011
- Regulation of subthalamic neuron activity by endocannabinoids Synapse, 2010; 64(9), 682 - 98
- Methods to Measure G Protein Coupled Receptor Activity for the Identification of Inverse Agonists Methods in Enzymology. Constitutive Activity and Inverse Agonism, 2010; 485, 261 - 273
—
10 elementu orrialdeko